Iroko Pharmaceuticals to Present at 6th Annual Biotech Showcase™
Monday, 06 January 2014 03:08
Jan. 6, 2014 13:00 UTC

Iroko Pharmaceuticals to Present at 6th Annual Biotech Showcase

PHILADELPHIA--(BUSINESS WIRE)-- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the

science of analgesia, announced today that the company will be presenting at Biotech Showcase™ 2014, taking place at the

Error. Page cannot be displayed. Please contact your service provider for more details. (8)

Parc 55 Wyndham in San Francisco. Iroko’s President and CEO, John Vavricka, will present on January 13, 2014, at 10:00 a.m. Pacific Time.

About Iroko Pharmaceuticals, LLC

Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. In addition to the

Iroko products that are marketed worldwide, the company has a robust pipeline of investigational lower dose NSAID products being developed using iCeutica Pty Ltd’s proprietary SoluMatrix Fine Particle Technology™. For more information, visit www.iroko.com.

SoluMatrix Fine Particle Technology™ is a trademark of iCeutica Pty Ltd, and is licensed to Iroko for exclusive use in NSAIDs.

Contacts

For Iroko Pharmaceuticals, LLC
Jessica Donnelly, 212-798-9819
or
Iroko Pharmaceuticals, LLC
Kate de Santis, 267-546-1682


Source: Iroko Pharmaceuticals, LLC




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 
BMR:1